VIDO-InterVac is one of North America’s largest containment level 2 and 3 vaccine and infectious disease research institutes. The state-of-the-art 250,000 square foot facility was designed and is approved for the study of Risk Group 2 and 3 infectious diseases. In addition to being Canada’s only research facility with containment level 3 large animal capacity, there is a 160 acre research farm for large animal studies up to containment level 2.
VIDO-InterVac’s laboratory space and animal accommodations are adaptable can accommodate varied research requirements.
The Hancock lab has developed popular, open source user-friendly tools for use by biologists and bioinformaticians. These encompass Network/Systems Biology approaches to analyzing large mammalian omic (particularly transcriptomic) data sets (NetworkAnalyst and InnateDB), a protein:protein interactions database, InnateDB, that is curated for immune system interactions but also incorporates all known experimentally verified and predicted interactions, and the Pseudomonas.com genome database.